Search

Your search keyword '"Yost, Jennifer"' showing total 393 results
Start Over Author "Yost, Jennifer"
393 results on '"Yost, Jennifer"'

5. The Dance of Family Engagement in School-Based Occupational Therapy: An Interpretive Description

Author

Kennedy, Jennifer N., Moll, Sandra, Missiuna, Cheryl, Yost, Jennifer, Terreberry, Sarah, and Campbell, Wenonah N.

Abstract

Family engagement is a central ideology in pediatric occupational therapy; however, the literature indicates that engaging families is challenging in the school- based context. The purpose of this study is to explore occupational therapists' and families' experiences of family engagement in school-based occupational therapy services and to propose stakeholder-informed improvements to service delivery. An interpretive description design was applied. Interviews were the primary method of data collection and were analyzed using inductive thematic analysis. Family engagement was depicted metaphorically as a group dance. The findings outline how therapists' and families' capabilities and expectations, trust, communication, emotional connections, and contextual factors interact to impact family engagement. Important changes to practice are required. Technology might enhance opportunities for connection and communication. The adoption of service delivery models that endorse a needs-based approach to service, rather than a 'one-size-fits-all' approach, are necessary to increase the value families place on this service.

Published
2022
Full Text
View/download PDF

13. Digitization protocol for scoring reproductive phenology from herbarium specimens of seed plants.

Author

Yost, Jennifer M, Sweeney, Patrick W, Gilbert, Ed, Nelson, Gil, Guralnick, Robert, Gallinat, Amanda S, Ellwood, Elizabeth R, Rossington, Natalie, Willis, Charles G, Blum, Stanley D, Walls, Ramona L, Haston, Elspeth M, Denslow, Michael W, Zohner, Constantin M, Morris, Ashley B, Stucky, Brian J, Carter, J Richard, Baxter, David G, Bolmgren, Kjell, Denny, Ellen G, Dean, Ellen, Pearson, Katelin D, Davis, Charles C, Mishler, Brent D, Soltis, Pamela S, and Mazer, Susan J

Subjects
citizen science, digitization workflows, herbarium specimens, ontology, phenology, Crop and Pasture Production
Abstract

Premise of the Study:Herbarium specimens provide a robust record of historical plant phenology (the timing of seasonal events such as flowering or fruiting). However, the difficulty of aggregating phenological data from specimens arises from a lack of standardized scoring methods and definitions for phenological states across the collections community. Methods and Results:To address this problem, we report on a consensus reached by an iDigBio working group of curators, researchers, and data standards experts regarding an efficient scoring protocol and a data-sharing protocol for reproductive traits available from herbarium specimens of seed plants. The phenological data sets generated can be shared via Darwin Core Archives using the Extended MeasurementOrFact extension. Conclusions:Our hope is that curators and others interested in collecting phenological trait data from specimens will use the recommendations presented here in current and future scoring efforts. New tools for scoring specimens are reviewed.

Published
2018

14. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians.

Author

Qaseem, Amir, Obley, Adam J., Shamliyan, Tatyana, Hicks, Lauri A., Harrod, Curtis S., Crandall, Carolyn J., Balk, Ethan M., Cooney, Thomas G., Cross Jr., J. Thomas, Fitterman, Nick, Lin, Jennifer S., Maroto, Michael, Miller, Matthew C., Shekelle, Paul, Tice, Jeffrey A., Tufte, Janice E., Etxeandia-Ikobaltzeta, Itziar, and Yost, Jennifer

Subjects
TYPE 2 diabetes, PHYSICIANS, MAJOR adverse cardiovascular events, ADULTS, MYOCARDIAL infarction, HYPERGLYCEMIA, CD26 antigen
Abstract

This ACP clinical guideline updates recommendations on newer pharmacologic treatments in adults with type 2 diabetes. It is based on 2 systematic reviews that summarize the effectiveness, comparative effectiveness, harms, and cost-effectiveness of SGLT2 inhibitors, GLP1 agonists, DPP4 inhibitors, and long-acting insulins as monotherapy or combination therapy in treating adults with type 2 diabetes mellitus. Description: The American College of Physicians (ACP) developed this clinical guideline to update recommendations on newer pharmacologic treatments of type 2 diabetes. This clinical guideline is based on the best available evidence for effectiveness, comparative benefits and harms, consideration of patients' values and preferences, and costs. Methods: This clinical guideline is based on a systematic review of the effectiveness and harms of newer pharmacologic treatments of type 2 diabetes, including glucagon-like peptide-1 (GLP-1) agonists, a GLP-1 agonist and glucose-dependent insulinotropic polypeptide agonist, sodium–glucose cotransporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, and long-acting insulins, used either as monotherapy or in combination with other medications. The Clinical Guidelines Committee prioritized the following outcomes, which were evaluated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach: all-cause mortality, major adverse cardiovascular events, myocardial infarction, stroke, hospitalization for congestive heart failure, progression of chronic kidney disease, serious adverse events, and severe hypoglycemia. Weight loss, as measured by percentage of participants who achieved at least 10% total body weight loss, was a prioritized outcome, but data were insufficient for network meta-analysis and were not rated with GRADE. Audience and Patient Population: The audience for this clinical guideline is physicians and other clinicians. The population is nonpregnant adults with type 2 diabetes. Recommendation 1: ACP recommends adding a sodium–glucose cotransporter-2 (SGLT-2) inhibitor or glucagon-like peptide-1 (GLP-1) agonist to metformin and lifestyle modifications in adults with type 2 diabetes and inadequate glycemic control (strong recommendation; high-certainty evidence). • Use an SGLT-2 inhibitor to reduce the risk for all-cause mortality, major adverse cardiovascular events, progression of chronic kidney disease, and hospitalization due to congestive heart failure. • Use a GLP-1 agonist to reduce the risk for all-cause mortality, major adverse cardiovascular events, and stroke. Recommendation 2: ACP recommends against adding a dipeptidyl peptidase-4 (DPP-4) inhibitor to metformin and lifestyle modifications in adults with type 2 diabetes and inadequate glycemic control to reduce morbidity and all-cause mortality (strong recommendation; high-certainty evidence). [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. Technology-Enabled Remote Monitoring and Self-Management — Vision for Patient Empowerment Following Cardiac and Vascular Surgery: User Testing and Randomized Controlled Trial Protocol

Author

Mcgillion, Michael H, Devereaux, P J, Yost, Jennifer, Turner, Andy, Bender, Duane, Scott, Ted, Carroll, Sandra L, Ritvo, Paul, Peter, Elizabeth, Lamy, Andre, Furze, Gill, Krull, Kirsten, Dunlop, Valerie, Good, Amber, Bedini, Debbie, Naus, Frank, Pettit, Shirley, Henry, Shaunattonie, Probst, Christine, Mills, Joseph, Gossage, Elaine, Travale, Irene, Duquette, Janine, Taberner, Christy, Bhavnani, Sanjeev, Khan, James, Cowan, David, Romeril, Eric, Lee, John, Collela, T, Choiniere, Manon, Busse, Jason W, Katz, Joel, Victor, J. Charles, Hoch, Jeffrey S, Isranauwatchai, W, Kaasalainen, Sharon, Ladak, Salima SJ, O'Keefe-McCarthy, Sheila, Parry, Monica, Sessler, Daniel, Stacey, Michael, Stevens, Bonnie, Stremler, Robyn, Thabane, Lehana, Watt-Watson, Judy, Whitlock, Richard, Macdermid, Joy C, Leegaard, Marit, McKelvie, Robert, Hillmer, Michael, Cooper, L, Arthur, Gavin, Sider, Krista, Oliver, Susan, Boyajian, Karen, Farrow, Mark, Lawton, Chris, Gamble, Darryl, Welch, Jake, S LeFort S, Field M, Clyne, Wendy, Ricuppero, Maria, Poole, Laurie, Russell-Wood, Karsten, Weber, Michael, McNeil, Jolene, Alpert, Robyn, Sharpe, Sarah, Bhella, Sue, Mohajer, David, Ponnambalam, Sem, Lakhani, Naeem, Khan, Rabia, and Liu, Peter

Subjects
Technology-Enabled, Remote, Monitoring, Self-Management, Vision, Patient, Empowerment, Following, Cardiac, Vascular, Surgery, Testing, Randomized, Controlled, Trial, Protocol
Published
2016

17. The Concept of Family Engagement in Education: What Are the Implications for School-Based Rehabilitation Service Providers?

Author

Kennedy, Jennifer N., Terreberry, Sarah, Moll, Sandra, Missiuna, Cheryl, Yost, Jennifer, Tomas, Vanessa, and Campbell, Wenonah N.

Abstract

The concept of family engagement within the rehabilitation literature focuses on clinic-based therapy sessions and is not particularly relevant to therapists working in school settings. In this study, we explored the concept of family engagement as represented in the education literature to provide school-based therapists with a better understanding of this concept in the school context. We applied scoping review methods for the literature search and screening process, and utilised concept evaluation methodology for our analysis of included articles. Specifically, we examined concept evaluation components, including definition, characteristics, boundaries, preconditions, and outcomes. The search strategy yielded 7112 documents, of which 17 met inclusion criteria. We did not find a clear definition of family engagement in the extant literature; however, there were some common characteristics. Our analysis of boundaries indicated family engagement and parent involvement are not synonymous but are closely linked. We also identified several preconditions for family engagement in education, including: an inviting and inclusive school culture; a broad understanding of engagement; positive educator-family relationships; and families' confidence, beliefs and supportive life contexts. Associated outcomes included academic achievement, high school completion and child social-emotional functioning. We proposed a broad definition based on our analysis of the included articles. Adopting a broad definition of family engagement is important for educators and school-based therapists to ensure families feel their efforts are meaningful. Educators and school-based therapists should consider their actions in supporting the individual needs of families, and the identified preconditions that support family engagement.

Published
2021
Full Text
View/download PDF

22. Living systematic reviews: 4. Living guideline recommendations

Author

Agoritsas, Thomas, Hilton, John, Perron, Caroline, Akl, Elie, Hodder, Rebecca, Pestridge, Charlotte, Albrecht, Lauren, Horsley, Tanya, Platt, Joanne, Armstrong, Rebecca, Nguyen, Phi Hung, Plovnick, Robert, Arno, Anneliese, Ivers, Noah, Quinn, Gail, Au, Agnes, Johnston, Renea, Rada, Gabriel, Bagg, Matthew, Jones, Arwel, Ravaud, Philippe, Boden, Catherine, Kahale, Lara, Richter, Bernt, Boisvert, Isabelle, Keshavarz, Homa, Ryan, Rebecca, Brandt, Linn, Kolakowsky-Hayner, Stephanie A., Salama, Dina, Brazinova, Alexandra, Nagraj, Sumanth Kumbargere, Salanti, Georgia, Buchbinder, Rachelle, Lasserson, Toby, Santaguida, Lina, Champion, Chris, Lawrence, Rebecca, Santesso, Nancy, Chandler, Jackie, Les, Zbigniew, Schünemann, Holger J., Charidimou, Andreas, Leucht, Stefan, Shemilt, Ian, Chou, Roger, Low, Nicola, Sherifali, Diana, Churchill, Rachel, Maas, Andrew, Siemieniuk, Reed, Cnossen, Maryse C., MacLehose, Harriet, Simmonds, Mark, Cossi, Marie-Joelle, Macleod, Malcolm, Skoetz, Nicole, Counotte, Michel, Marshall, Iain, Soares-Weiser, Karla, Craigie, Samantha, Marshall, Rachel, Srikanth, Velandai, Dahm, Philipp, Martin, Nicole, Sullivan, Katrina, Danilkewich, Alanna, Martínez García, Laura, Synnot, Anneliese, Danko, Kristen, Mavergames, Chris, Taylor, Mark, Donoghue, Emma, Maxwell, Lara J., Thayer, Kris, Dressler, Corinna, McAuley, James, Thomas, James, Egan, Cathy, McDonald, Steve, Tritton, Roger, Elliott, Julian, McKenzie, Joanne, Tsafnat, Guy, Elliott, Sarah A., Meerpohl, Joerg, Tugwell, Peter, Etxeandia, Itziar, Merner, Bronwen, Turgeon, Alexis, Featherstone, Robin, Mondello, Stefania, Turner, Tari, Foxlee, Ruth, Morley, Richard, van Valkenhoef, Gert, Garner, Paul, Munafo, Marcus, Vandvik, Per, Gerrity, Martha, Munn, Zachary, Wallace, Byron, Glasziou, Paul, Murano, Melissa, Wallace, Sheila A., Green, Sally, Newman, Kristine, Watts, Chris, Grimshaw, Jeremy, Nieuwlaat, Robby, Weeks, Laura, Gurusamy, Kurinchi, Nikolakopoulou, Adriani, Weigl, Aaron, Haddaway, Neal, Noel-Storr, Anna, Wells, George, Hartling, Lisa, O'Connor, Annette, Wiercioch, Wojtek, Hayden, Jill, Page, Matthew, Wolfenden, Luke, Helfand, Mark, Pahwa, Manisha, Yepes Nuñez, Juan José, Higgins, Julian, Pardo, Jordi Pardo, Yost, Jennifer, Hill, Sophie, Pearson, Leslea, Akl, Elie A., Meerpohl, Joerg J., and Kahale, Lara A.

Published
2017
Full Text
View/download PDF

23. Living systematic reviews: 3. Statistical methods for updating meta-analyses

Author

Agoritsas, Thomas, Hilton, John, Perron, Caroline, Akl, Elie, Hodder, Rebecca, Pestridge, Charlotte, Albrecht, Lauren, Horsley, Tanya, Platt, Joanne, Armstrong, Rebecca, Nguyen, Phi Hung, Plovnick, Robert, Arno, Anneliese, Ivers, Noah, Quinn, Gail, Au, Agnes, Johnston, Renea, Rada, Gabriel, Bagg, Matthew, Jones, Arwel, Ravaud, Philippe, Boden, Catherine, Kahale, Lara, Richter, Bernt, Boisvert, Isabelle, Keshavarz, Homa, Ryan, Rebecca, Brandt, Linn, Kolakowsky-Hayner, Stephanie A., Salama, Dina, Brazinova, Alexandra, Nagraj, Sumanth Kumbargere, Salanti, Georgia, Buchbinder, Rachelle, Lasserson, Toby, Santaguida, Lina, Champion, Chris, Lawrence, Rebecca, Santesso, Nancy, Chandler, Jackie, Les, Zbigniew, Schünemann, Holger J., Charidimou, Andreas, Leucht, Stefan, Shemilt, Ian, Chou, Roger, Low, Nicola, Sherifali, Diana, Churchill, Rachel, Maas, Andrew, Siemieniuk, Reed, Cnossen, Maryse C., MacLehose, Harriet, Simmonds, Mark, Cossi, Marie-Joelle, Macleod, Malcolm, Skoetz, Nicole, Counotte, Michel, Marshall, Iain, Soares-Weiser, Karla, Craigie, Samantha, Marshall, Rachel, Srikanth, Velandai, Dahm, Philipp, Martin, Nicole, Sullivan, Katrina, Danilkewich, Alanna, Martínez García, Laura, Synnot, Anneliese, Danko, Kristen, Mavergames, Chris, Taylor, Mark, Donoghue, Emma, Maxwell, Lara J., Thayer, Kris, Dressler, Corinna, McAuley, James, Thomas, James, Egan, Cathy, McDonald, Steve, Tritton, Roger, Elliott, Julian, McKenzie, Joanne, Tsafnat, Guy, Elliott, Sarah A., Meerpohl, Joerg, Tugwell, Peter, Etxeandia, Itziar, Merner, Bronwen, Turgeon, Alexis, Featherstone, Robin, Mondello, Stefania, Turner, Tari, Foxlee, Ruth, Morley, Richard, van Valkenhoef, Gert, Garner, Paul, Munafo, Marcus, Vandvik, Per, Gerrity, Martha, Munn, Zachary, Wallace, Byron, Glasziou, Paul, Murano, Melissa, Wallace, Sheila A., Green, Sally, Newman, Kristine, Watts, Chris, Grimshaw, Jeremy, Nieuwlaat, Robby, Weeks, Laura, Gurusamy, Kurinchi, Nikolakopoulou, Adriani, Weigl, Aaron, Haddaway, Neal, Noel-Storr, Anna, Wells, George, Hartling, Lisa, O'Connor, Annette, Wiercioch, Wojtek, Hayden, Jill, Page, Matthew, Wolfenden, Luke, Helfand, Mark, Pahwa, Manisha, Yepes Nuñez, Juan José, Higgins, Julian, Pardo, Jordi Pardo, Yost, Jennifer, Hill, Sophie, and Pearson, Leslea

Published
2017
Full Text
View/download PDF

24. Living systematic review: 1. Introduction—the why, what, when, and how

Author

Agoritsas, Thomas, Hilton, John, Perron, Caroline, Akl, Elie, Hodder, Rebecca, Pestridge, Charlotte, Albrecht, Lauren, Horsley, Tanya, Platt, Joanne, Armstrong, Rebecca, Nguyen, Phi Hung, Plovnick, Robert, Arno, Anneliese, Ivers, Noah, Quinn, Gail, Au, Agnes, Johnston, Renea, Rada, Gabriel, Bagg, Matthew, Jones, Arwel, Ravaud, Philippe, Boden, Catherine, Kahale, Lara, Richter, Bernt, Boisvert, Isabelle, Keshavarz, Homa, Ryan, Rebecca, Brandt, Linn, Kolakowsky-Hayner, Stephanie A., Salama, Dina, Brazinova, Alexandra, Nagraj, Sumanth Kumbargere, Salanti, Georgia, Buchbinder, Rachelle, Lasserson, Toby, Santaguida, Lina, Champion, Chris, Lawrence, Rebecca, Santesso, Nancy, Chandler, Jackie, Les, Zbigniew, Schünemann, Holger J., Charidimou, Andreas, Leucht, Stefan, Shemilt, Ian, Chou, Roger, Low, Nicola, Sherifali, Diana, Churchill, Rachel, Maas, Andrew, Siemieniuk, Reed, Cnossen, Maryse C., MacLehose, Harriet, Simmonds, Mark, Cossi, Marie-Joelle, Macleod, Malcolm, Skoetz, Nicole, Counotte, Michel, Marshall, Iain, Soares-Weiser, Karla, Craigie, Samantha, Marshall, Rachel, Srikanth, Velandai, Dahm, Philipp, Martin, Nicole, Sullivan, Katrina, Danilkewich, Alanna, Martínez García, Laura, Synnot, Anneliese, Danko, Kristen, Mavergames, Chris, Taylor, Mark, Donoghue, Emma, Maxwell, Lara J., Thayer, Kris, Dressler, Corinna, McAuley, James, Thomas, James, Egan, Cathy, McDonald, Steve, Tritton, Roger, Elliott, Julian, McKenzie, Joanne, Tsafnat, Guy, Elliott, Sarah A., Meerpohl, Joerg, Tugwell, Peter, Etxeandia, Itziar, Merner, Bronwen, Turgeon, Alexis, Featherstone, Robin, Mondello, Stefania, Turner, Tari, Foxlee, Ruth, Morley, Richard, van Valkenhoef, Gert, Garner, Paul, Munafo, Marcus, Vandvik, Per, Gerrity, Martha, Munn, Zachary, Wallace, Byron, Glasziou, Paul, Murano, Melissa, Wallace, Sheila A., Green, Sally, Newman, Kristine, Watts, Chris, Grimshaw, Jeremy, Nieuwlaat, Robby, Weeks, Laura, Gurusamy, Kurinchi, Nikolakopoulou, Adriani, Weigl, Aaron, Haddaway, Neal, Noel-Storr, Anna, Wells, George, Hartling, Lisa, O'Connor, Annette, Wiercioch, Wojtek, Hayden, Jill, Page, Matthew, Wolfenden, Luke, Helfand, Mark, Pahwa, Manisha, Yepes Nuñez, Juan José, Higgins, Julian, Pardo, Jordi Pardo, Yost, Jennifer, Hill, Sophie, Pearson, Leslea, Elliott, Julian H., Akl, Elie A., and Tovey, David

Published
2017
Full Text
View/download PDF

25. Living systematic reviews: 2. Combining human and machine effort

Author

Agoritsas, Thomas, Hilton, John, Perron, Caroline, Akl, Elie, Hodder, Rebecca, Pestridge, Charlotte, Albrecht, Lauren, Horsley, Tanya, Platt, Joanne, Armstrong, Rebecca, Nguyen, Phi Hung, Plovnick, Robert, Arno, Anneliese, Ivers, Noah, Quinn, Gail, Au, Agnes, Johnston, Renea, Rada, Gabriel, Bagg, Matthew, Jones, Arwel, Ravaud, Philippe, Boden, Catherine, Kahale, Lara, Richter, Bernt, Boisvert, Isabelle, Keshavarz, Homa, Ryan, Rebecca, Brandt, Linn, Kolakowsky-Hayner, Stephanie A., Salama, Dina, Brazinova, Alexandra, Nagraj, Sumanth Kumbargere, Salanti, Georgia, Buchbinder, Rachelle, Lasserson, Toby, Santaguida, Lina, Champion, Chris, Lawrence, Rebecca, Santesso, Nancy, Chandler, Jackie, Les, Zbigniew, Schünemann, Holger J., Charidimou, Andreas, Leucht, Stefan, Shemilt, Ian, Chou, Roger, Low, Nicola, Sherifali, Diana, Churchill, Rachel, Maas, Andrew, Siemieniuk, Reed, Cnossen, Maryse C., MacLehose, Harriet, Simmonds, Mark, Cossi, Marie-Joelle, Macleod, Malcolm, Skoetz, Nicole, Counotte, Michel, Marshall, Iain, Soares-Weiser, Karla, Craigie, Samantha, Marshall, Rachel, Srikanth, Velandai, Dahm, Philipp, Martin, Nicole, Sullivan, Katrina, Danilkewich, Alanna, Martínez García, Laura, Synnot, Anneliese, Danko, Kristen, Mavergames, Chris, Taylor, Mark, Donoghue, Emma, Maxwell, Lara J., Thayer, Kris, Dressler, Corinna, McAuley, James, Thomas, James, Egan, Cathy, McDonald, Steve, Tritton, Roger, Elliott, Julian, McKenzie, Joanne, Tsafnat, Guy, Elliott, Sarah A., Meerpohl, Joerg, Tugwell, Peter, Etxeandia, Itziar, Merner, Bronwen, Turgeon, Alexis, Featherstone, Robin, Mondello, Stefania, Turner, Tari, Foxlee, Ruth, Morley, Richard, van Valkenhoef, Gert, Garner, Paul, Munafo, Marcus, Vandvik, Per, Gerrity, Martha, Munn, Zachary, Wallace, Byron, Glasziou, Paul, Murano, Melissa, Wallace, Sheila A., Green, Sally, Newman, Kristine, Watts, Chris, Grimshaw, Jeremy, Nieuwlaat, Robby, Weeks, Laura, Gurusamy, Kurinchi, Nikolakopoulou, Adriani, Weigl, Aaron, Haddaway, Neal, Noel-Storr, Anna, Wells, George, Hartling, Lisa, O'Connor, Annette, Wiercioch, Wojtek, Hayden, Jill, Page, Matthew, Wolfenden, Luke, Helfand, Mark, Pahwa, Manisha, Yepes Nuñez, Juan José, Higgins, Julian, Pardo, Jordi Pardo, Yost, Jennifer, Hill, Sophie, Pearson, Leslea, and McDonald, Steven

Published
2017
Full Text
View/download PDF

27. Evidence Synthesis International (ESI): Position Statement

Author

Gough, David, Davies, Phil, Jamtvedt, Gro, Langlois, Etienne, Littell, Julia, Lotfi, Tamara, Masset, Edoardo, Merlin, Tracy, Pullin, Andrew S., Ritskes-Hoitinga, Merel, Røttingen, John-Arne, Sena, Emily, Stewart, Ruth, Tovey, David, White, Howard, Yost, Jennifer, Lund, Hans, and Grimshaw, Jeremy

Published
2020
Full Text
View/download PDF

29. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2).

Author

Qaseem, Amir, Yost, Jennifer, Abraham, George M., Andrews, Rebecca, Jokela, Janet A., Miller, Matthew C., Humphrey, Linda L., Obley, Adam J., Akl, Elie A., Dunn, Andrew, Forciea, Mary Ann, Haeme, Ray, Kansagara, Devan L., Lee, Rachael, Mackey, Katherine, Marcucci, Maura, Saini, Sameer D., Tschanz, CDR Mark P., Wilt, Timothy J., and Carroll, Kate

Subjects
*COVID-19 treatment, *SARS-CoV-2 Omicron variant, *PHYSICIANS, *MEDICAL sciences, *HEALTH policy
Abstract

The Population Health and Medical Science Committee of the American College of Physicians (ACP) updates the living, rapid practice points on the treatment of adults with COVID-19 in an outpatient setting. Practice points are based on a living, rapid review done by the ACP Center for Evidence Reviews at Cochrane Austria at the University for Continuing Education Krems. Description: Evidence for the use of outpatient treatments in adults with confirmed COVID-19 continues to evolve with new data. This is version 2 of the American College of Physicians (ACP) living, rapid practice points focusing on 22 outpatient treatments for COVID-19, specifically addressing the dominant SARS-CoV-2 Omicron variant. Methods: The Population Health and Medical Science Committee (formerly the Scientific Medical Policy Committee) developed this version of the living, rapid practice points on the basis of a living, rapid review done by the ACP Center for Evidence Reviews at Cochrane Austria at the University for Continuing Education Krems (Danube University Krems). This topic will be maintained as living and rapid by continually monitoring and assessing the impact of new evidence. Practice Point 1: Consider molnupiravir to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Practice Point 2: Consider nirmatrelvir–ritonavir combination therapy to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease. Practice Point 3: Do not use ivermectin to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting. Practice Point 4: Do not use sotrovimab to treat patients with confirmed mild to moderate COVID-19 in the outpatient setting. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

30. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Author

Qaseem, Amir, Yost, Jennifer, Etxeandia-Ikobaltzeta, Itziar, Forciea, Mary Ann, Abraham, George M., Miller, Matthew C., Obley, Adam J., Humphrey, Linda L., Akl, Elie A., Andrews, Rebecca, Dunn, Andrew, Haeme, Ray, Kansagara, Devan L., and P. Tschanz, CDR Mark

Subjects
medicine.medical_specialty, COVID-19 Vaccines, viruses, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), MEDLINE, Appropriate use, Antibodies, Viral, COVID-19 Testing, Physicians, Health care, Agency (sociology), medicine, Internal Medicine, Humans, skin and connective tissue diseases, Intensive care medicine, business.industry, SARS-CoV-2, Public health, fungi, Foundation (evidence), COVID-19, General Medicine, biochemical phenomena, metabolism, and nutrition, Immunity, Innate, respiratory tract diseases, body regions, Antibody response, Reinfection, Antibody Formation, business, Clinical Guidelines
Abstract

Antibody tests for SARS-CoV-2, the virus that causes COVID-19, are widely available. These practice points help clinicians, patients, and public health professionals understand how to use and interpret these results on the basis of the available evidence. The practice points will be updated as more evidence becomes available., Description: The widespread availability of SARS-CoV-2 antibody tests raises important questions for clinicians, patients, and public health professionals related to the appropriate use and interpretation of these tests. The Scientific Medical Policy Committee (SMPC) of the American College of Physicians developed these rapid, living practice points to summarize the current and best available evidence on the antibody response to SARS-CoV-2 infection, antibody durability after initial infection with SARS-CoV-2, and antibody protection against reinfection with SARS-CoV-2. Methods: The SMPC developed these rapid, living practice points based on a rapid and living systematic evidence review done by the Portland VA Research Foundation and funded by the Agency for Healthcare Research and Quality. Ongoing literature surveillance is planned through December 2021. When new studies are identified and a full update of the evidence review is published, the SMPC will assess the new evidence and any effect on the practice points. Practice Points: Practice Point 1: Do not use SARS-CoV-2 antibody tests for the diagnosis of SARS-CoV-2 infection. Practice Point 2: Antibody tests can be useful for the purpose of estimating community prevalence of SARS-CoV-2 infection. Practice Point 3: Current evidence is uncertain to predict presence, level, or durability of natural immunity conferred by SARS-CoV-2 antibodies against reinfection (after SARS-CoV-2 infection).

Published
2022

31. A thematic analysis of shared experiences of essential health and support personnel in the COVID-19 pandemic

Author

Copel, Linda Carman, primary, Smeltzer, Suzanne C., additional, Byrne, Christine D., additional, Chen, Mu-Hsun, additional, Havens, Donna S., additional, Kaufmann, Peter, additional, Brom, Heather, additional, Durning, Jennifer Dean, additional, Maldonado, Linda, additional, Bradley, Patricia K., additional, Mensinger, Janell, additional, and Yost, Jennifer, additional

Published
2023
Full Text
View/download PDF

36. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (Version 2).

Author

Qaseem, Amir, Harrod, Curtis S., Crandall, Carolyn J., Wilt, Timothy J., Balk, Ethan M., Cooney, Thomas G., Cross Jr, J. Thomas, Fitterman, Nick, Hicks, Lauri A., Lin, Jennifer S., Maroto, Michael, Obley, Adam J., Owens, Douglas K., Tice, Jeffrey, Tufte, Janice E., Carroll, Kate, Etxeandia-Ikobaltzeta, Itziar, Shamliyan, Tatyana, and Yost, Jennifer

Subjects
COLORECTAL cancer, PHYSICIANS, FECAL occult blood tests, EARLY detection of cancer, ADULTS
Abstract

This is an updated guidance statement from the American College of Physicians on screening for colorectal cancer. The article provides guidance on the ages to start and stop screening and selection of type and frequency of screening tests in asymptomatic, average-risk adults on the basis of a critical review of existing guidelines and associated evidence reviews and modeling studies. Description: The purpose of this updated guidance statement is to guide clinicians on screening for colorectal cancer (CRC) in asymptomatic average-risk adults. The intended audience is all clinicians. The population is asymptomatic adults at average risk for CRC. Methods: This updated guidance statement was developed using recently published and critically appraised clinical guidelines from national guideline developers since the publication of the American College of Physicians' 2019 guidance statement, "Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults." The authors searched for national guidelines from the United States and other countries published in English using PubMed and the Guidelines International Network library from 1 January 2018 to 24 April 2023. The authors also searched for updates of guidelines included in the first version of our guidance statement. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument was used to assess the quality of eligible guidelines. Two guidelines were selected for adoption and adaptation by raters on the basis of the highest average overall AGREE II quality scores. The evidence reviews and modeling studies for these 2 guidelines were also used to synthesize the evidence of diagnostic test accuracy, effectiveness, and harms of CRC screening interventions and to develop our guidance statements. Guidance Statement 1: Clinicians should start screening for colorectal cancer in asymptomatic average-risk adults at age 50 years. Guidance Statement 2: Clinicians should consider not screening asymptomatic average-risk adults between the ages of 45 to 49 years. Clinicians should discuss the uncertainty around benefits and harms of screening in this population. Guidance Statement 3: Clinicians should stop screening for colorectal cancer in asymptomatic average-risk adults older than 75 years or in asymptomatic average-risk adults with a life expectancy of 10 years or less. Guidance Statement 4a: Clinicians should select a screening test for colorectal cancer in consultation with their patient based on a discussion of benefits, harms, costs, availability, frequency, and patient values and preferences. Guidance Statement 4b: Clinicians should select among a fecal immunochemical or high-sensitivity guaiac fecal occult blood test every 2 years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus a fecal immunochemical test every 2 years as a screening test for colorectal cancer. Guidance Statement 4c: Clinicians should not use stool DNA, computed tomography colonography, capsule endoscopy, urine, or serum screening tests for colorectal cancer. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

37. Systematic review of the cost-effectiveness of nurse practitioners and clinical nurse specialists: What is the quality of the evidence?

Author

Donald, Faith, primary, Kilpatrick, Kelley, primary, Reid, Kim, primary, Carter, Nancy, primary, Martin-Misener, Ruth, primary, Bryant-Lukosius, Denise, primary, Harbman, Patricia, primary, Kaasalainen, Sharon, primary, Marshall, Deborah A., primary, Charbonneau-Smith, Renee, primary, Donald, Erin E., primary, Lloyd, Monique, primary, Wickson-Griffiths, Abigail, primary, Yost, Jennifer, primary, Baxter, Pamela, primary, Sangster-Gormley, Esther, primary, Hubley, Pamela, primary, Laflamme, Célyne, primary, Campbell-Yeo, Marsha, primary, Price, Sheri, primary, Boyko, Jennifer, primary, and DiCenso, Alba, primary

Published
2022
Full Text
View/download PDF

42. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2, Update Alert).

Author

Qaseem, Amir, Yost, Jennifer, Abraham, George M., Andrews, Rebecca A., Jokela, Janet A., Miller, Matthew C., Humphrey, Linda L., Obley, Adam J., Dunn, Andrew S., Haeme, Ray, Lee, Rachael A., Saini, Sameer D., Tschanz, Mark P., Etxeandia-Ikobaltzeta, Itziar, Harrod, Curtis S., and Shamliyan, Tatyana

Subjects
*SARS-CoV-2 Omicron variant, *COVID-19 treatment, *MOLNUPIRAVIR, *MEDICAL sciences, *IVERMECTIN
Abstract

This document is an update alert from the American College of Physicians (ACP) on the outpatient treatment of confirmed COVID-19 in adults, specifically focusing on the SARS-CoV-2 Omicron variant. The ACP Center for Evidence Reviews identified 9 newly published studies that met the inclusion criteria for the surveillance search. The new evidence supports the use of molnupiravir and nirmatrelvir-ritonavir combination therapy in the outpatient treatment of adults with confirmed COVID-19 at a high risk for severe disease. The document also states that ivermectin and sotrovimab should not be used for the treatment of mild to moderate COVID-19 in the outpatient setting. The Population Health and Medical Science Committee plans to perform a focused update of the evidence review and practice points in light of ongoing studies. [Extracted from the article]

Published
2024
Full Text
View/download PDF

43. Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert 2).

Author

Qaseem, Amir, Owens, Douglas K., Etxeandia-Ikobaltzeta, Itziar, Tufte, Janice E., Cross Jr., J. Thomas, Wilt, Timothy J., Crandall, Carolyn J., Hicks, Lauri A., Balk, Ethan M., Cooney, Thomas G., Fitterman, Nick, Lin, Jennifer S., Maroto, Michael, Miller, Matthew C., Obley, Adam J., Shekelle, Paul G., Tice, Jeffrey A., Harrod, Curtis S., and Yost, Jennifer

Subjects
INTERPERSONAL psychotherapy, MENTAL depression, SECOND-generation antidepressants, PSYCHOTHERAPY, ADULTS
Abstract

This document is an update alert from the American College of Physicians (ACP) on nonpharmacologic and pharmacologic treatments for adults with major depressive disorder. The ACP conducted a surveillance search and identified one new study that met the inclusion criteria. However, the new evidence did not change the prior conclusions of the living systematic review. As a result, the ACP decided that an update of the review is not necessary at this time. The ACP reaffirms the recommendations in the living clinical guideline on nonpharmacologic and pharmacologic treatments for major depressive disorder. [Extracted from the article]

Published
2024
Full Text
View/download PDF

47. Meta-research evaluating redundancy and use of systematic reviews when planning new studies in health research: a scoping review

Author

Lund, Hans, primary, Robinson, Karen A., additional, Gjerland, Ane Kjellaug Brekke, additional, Nykvist, Hanna, additional, Drachen, Thea Marie, additional, Christensen, Robin, additional, Juhl, Carsten Bogh, additional, Jamtvedt, Gro, additional, Nortvedt, Monica Wammen, additional, Bjerrum, Merete, additional, Westmore, Matthew, additional, Yost, Jennifer, additional, and Brunnhuber, Klara, additional

Published
2022
Full Text
View/download PDF

49. Vulnerability, loss, and coping experiences of health care workers and first responders during the covid-19 pandemic: a qualitative study

Author

Smeltzer, Suzanne C., primary, Copel, Linda Carman, additional, Bradley, Patricia K., additional, Maldonado, Linda Tina, additional, D. Byrne, Christine, additional, Durning, Jennifer Dean, additional, Havens, Donna Sullivan, additional, Brom, Heather, additional, Mensinger, Janell L., additional, and Yost, Jennifer, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results